I am Associate Professor in Consciousness Studies at University of Copenhagen and Neurobiology Research Unit at Copenhagen University Hospital Rigshospitalet, where I conduct research from an integrated experimental approach with the aim of contributing to an interdisciplinary understanding of neurobiological and psychological factors in human health. My overall research focus is the study of pharmacological manipulations of the serotonin (5-HT) system, where I mainly focus on effects of serotonin 2A receptor (5-HT2AR) agonism with psychedelics such as psilocybin and LSD. To understand how 5-HT more broadly is involved in neurocognition in the healthy and disordered brain, I also study associations of various 5-HT receptors using PET imaging, i.e., 5-HT2AR, 5-HT4R, 5-HTT and 5-HT1BR with personality and neurocognition. I am co-founder of Danish Centre for Psychedelic Research (DCPR) and head of Copenhagen University Clinic for Psychedelic Research, where I train students and clinicians in safe administration of psilocybin and supervise psychedelic sessions across studies conducted at DCPR. A key research interest of mine is the effects of ‘extra-pharmacological’ factors, e.g., use of music and psychological setting, on the clinical effects of psilocybin. I am closely affiliated with the Centre for Psychedelic Research at Imperial College London, United Kingdom, and the Karolinska Institute, Sweden, where I am Co-PI of two studies investigating neurocognitive mechanisms of psilocybin therapy for obsessive compulsive disorder and effect of psilocybin therapy for depression in cancer patients, respectively.